CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...

GoNitro Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Espero announced the ...

The Nitrostat (nitroglycerin) sublingual tablet brand had US sales of approximately $108 million MAT for the most recent twelve months ending in March 2016 Dr Reddy’s Laboratories (DRL) has launched ...

Dr Reddy’s Laboratories today said it has launched nitroglycerin sublingual tablets, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in the US. The drug which ...

GoNitro Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (USFDA) to market Nitroglycerin Sublingual tablets in the strengths of 0.3 mg, 0.4mg and 0.6mg. The drug is ...

THE value of sublingual administration of nitroglycerin for relief of attacks of angina pectoris is well established. Nitroglycerin has also been advocated as a prophylactic — before exercise and so ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued warning letters yesterday to two companies, Glenmark Generics of Mahwah, N.J. and Konec Inc. of ...

Dr. Reddy’s Laboratories Ltd has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat (Nitroglycerin) sublingual tablets in ...